Bio Techne | TECH - Ebit



金融业
股票价格
USD
资产
USD 2.55B
现金及等价物
USD 209.82M
销售成本
USD 103.13M
流动资产
USD 688.05M
流动负债
USD 153.28M
债务
USD 200M
股息收益率
0.61
EBIT
USD 75.5M
EBITDA
USD 116.71M
员工
3.1K
EPS每股收益
USD 0.53
股本和储备
USD 2.09B
销售毛利
USD 208.29M
债务利息支出
USD 2.17M
利息收入
USD 897K
贷款资金
USD 200M
市值
USD 7.83B
净收入
USD 51.05M
营业费用
USD 235.92M
营业利润
USD 75.5M
普通股股本
USD 156.45M
PE价格收益
38.75
税前利润
USD 50.78M
销售收入
USD 311.4M
销售和管理费用
USD 109.34M
股票
USD 201.18M
贸易债权人
USD 95.6M
应收帐款人
USD 214.56M


Ebit 更改 日
Agilent USD 399M 46M 2026-03
Becton, Dickinson and Co. USD 627M 36M 2026-03
Bio Techne USD 75.49M 21.03M 2026-03
Bio-Rad Laboratories USD 941.3M 1.36B 2025-12
Bruker USD 10.2M 66.1M 2026-03
Charles River Laboratories USD 119.9M 44.08M 2026-03
Danaher USD 1.34B 158M 2026-03
Illumina USD 239M 17M 2026-03
IQVIA Holdings USD 565M 2.11B 2026-03
Merck EUR 1.05B 572M 2026-03
Mettler Toledo International USD 233.93M 118M 2026-03
OraSure Technologies USD -13.59M 2.13M 2025-12
Pacific Biosciences Of California USD -53.19M 35.08M 2025-12
Repligen USD 19.98M 13K 2026-03
Revvity USD 82.77M 63.06M 2026-03
Standard Biotools USD -21.92M 10.97M 2025-12
Thermo Fisher Scientific USD 1.91B 389M 2026-03
Waters USD 148M 122.52M 2026-03